Literature DB >> 21377582

Ablative therapies for colorectal liver metastases.

Russell E Brown1, Robert C G Martin, Charles R Scoggins.   

Abstract

Ablative therapies remain a useful adjunct in the multidisciplinary treatment of patients with colorectal liver metastases not amenable to hepatic resection. This review summarizes the rationale, underlying mechanisms, techniques, complications, and outcomes of current and emerging ablative modalities. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2010        PMID： 21377582     DOI： 10.1016/j.soc.2010.11.005

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  3 in total

1.  Longterm survival outcomes of patients undergoing treatment with radiofrequency ablation for hepatocellular carcinoma and metastatic colorectal cancer liver tumors.

Authors:  Iswanto Sucandy; Susannah Cheek; Benjamin J Golas; Allan Tsung; David A Geller; James W Marsh
Journal:  HPB (Oxford)       Date:  2016-07-09       Impact factor: 3.647

2.  Radiofrequency ablation compared to resection in early-stage hepatocellular carcinoma.

Authors:  Samer Tohme; David A Geller; Jon S Cardinal; Hui-Wei Chen; Vignesh Packiam; Srinevas Reddy; Jennifer Steel; James W Marsh; Allan Tsung
Journal:  HPB (Oxford)       Date:  2012-08-12       Impact factor: 3.647

3.  Impact of treatment modality and number of lesions on recurrence and survival outcomes after treatment of colorectal cancer liver metastases.

Authors:  Akshat Saxena; Terence C Chua; Francis C Chu; Keh Min Ng; Pradyumna Herle; David L Morris
Journal:  J Gastrointest Oncol       Date:  2014-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.